SARS-CoV-2 fusion-peptide-directed antibodies are elicited by natural infection and can mediate broad sarbecovirus neutralization.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- SARS-CoV-2 fusion-peptide-directed antibodies are elicited by natural infection and can mediate broad sarbecovirus neutralization.
- Published In:
- Cell reports, 45(2), 116954 (2026)
- Authors:
- Roederer, Alex L, Li, Chia Jung, Lim, Eunice, Cao, Yi, Ronsard, Larance, Lingwood, Daniel, Canaday, David H, Gravenstein, Stefan, Balazs, Alejandro B
- Database ID:
- RPEP-16005
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16005APA
Roederer, Alex L; Li, Chia Jung; Lim, Eunice; Cao, Yi; Ronsard, Larance; Lingwood, Daniel; Canaday, David H; Gravenstein, Stefan; Balazs, Alejandro B. (2026). SARS-CoV-2 fusion-peptide-directed antibodies are elicited by natural infection and can mediate broad sarbecovirus neutralization.. Cell reports, 45(2), 116954. https://doi.org/10.1016/j.celrep.2026.116954
MLA
Roederer, Alex L, et al. "SARS-CoV-2 fusion-peptide-directed antibodies are elicited by natural infection and can mediate broad sarbecovirus neutralization.." Cell reports, 2026. https://doi.org/10.1016/j.celrep.2026.116954
RethinkPeptides
RethinkPeptides Research Database. "SARS-CoV-2 fusion-peptide-directed antibodies are elicited b..." RPEP-16005. Retrieved from https://rethinkpeptides.com/research/roederer-2026-sarscov2-fusionpeptidedirected-antibodies-are
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.